Morgan Stanley Bolsters Ryan Specialty Target to $42

Morgan Stanley has raised its target price for Ryan Specialty Holdings to $42 from $39, according to an analyst note. This increase reflects an updated valuation of the NYSE-listed specialty insurance firm. Morgan Stanley analyst Bob Huang maintained an Overweight rating on the company while making this change.

The revised target suggests that investors can expect potential upside from the stock relative to its sector peers. However, Goldman Sachs analyst Robert Cox has maintained a Neutral rating with a price target of $40, up from $35.